Prognostic value of the C-PLAN index in patients with advanced esophageal cancer treated with immune checkpoint inhibitors
The C-PLAN index provides a robust and clinically meaningful prognostic tool for patients with advanced esophageal cancer treated with immune checkpoint inhibitors. Its superior predictive performance compared to traditional markers such as NLR highlights its potential utility in risk stratification and guiding treatment decisions.
Authors
- Junxing Huang
- Yawen Gu (ORCID: https://orcid.org/0009-0002-7431-0661)
- Xiuyuan Yang (ORCID: https://orcid.org/0009-0009-6389-8843)
- Hu Zhang
- Shanshan Shao (ORCID: https://orcid.org/0009-0009-7392-2069)
Institutions
- Nantong University (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- Clinics
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2026.100917
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00